J. Terencio

404 total citations
14 papers, 262 citations indexed

About

J. Terencio is a scholar working on Molecular Biology, Infectious Diseases and Physiology. According to data from OpenAlex, J. Terencio has authored 14 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Infectious Diseases and 4 papers in Physiology. Recurrent topics in J. Terencio's work include Alzheimer's disease research and treatments (3 papers), Leprosy Research and Treatment (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). J. Terencio is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Leprosy Research and Treatment (3 papers) and Neuroscience and Neuropharmacology Research (2 papers). J. Terencio collaborates with scholars based in Spain, France and United States. J. Terencio's co-authors include Antonio Guglietta, Rafael León, Manuela G. López, Antonio G. Garcı́a, Mércedes Villarroya, José Marco‐Contelles, Cristóbal de los Rı́os, Eva Méndez, Albert Palomer and Maria Piqué and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Journal of Lipid Research.

In The Last Decade

J. Terencio

12 papers receiving 258 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Terencio Spain	8	137	81	71	55	41	14	262
Francesco Mesiti Italy	9	82 0.6×	111 1.4×	111 1.6×	58 1.1×	56 1.4×	12	333
Deepika Saraswat India	10	116 0.8×	36 0.4×	128 1.8×	32 0.6×	28 0.7×	31	359
Flávia P. Dias Viegas Brazil	6	124 0.9×	79 1.0×	124 1.7×	85 1.5×	30 0.7×	9	325
Huangquan Lin China	13	170 1.2×	90 1.1×	130 1.8×	59 1.1×	25 0.6×	24	453
Manjiong Wang China	11	72 0.5×	75 0.9×	167 2.4×	62 1.1×	25 0.6×	19	280
Antonis Gavalas Greece	11	203 1.5×	75 0.9×	64 0.9×	19 0.3×	16 0.4×	20	331
Andrey Voronkov Russia	8	85 0.6×	45 0.6×	74 1.0×	16 0.3×	33 0.8×	79	258
Alberto Ongaro Italy	11	98 0.7×	67 0.8×	199 2.8×	55 1.0×	14 0.3×	36	347
Syed Jawad Ali Shah Pakistan	13	161 1.2×	46 0.6×	164 2.3×	29 0.5×	34 0.8×	35	379
Neeraj Masand India	8	95 0.7×	63 0.8×	70 1.0×	80 1.5×	12 0.3×	32	265

Countries citing papers authored by J. Terencio

Since Specialization

Citations

This map shows the geographic impact of J. Terencio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Terencio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Terencio more than expected).

Fields of papers citing papers by J. Terencio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Terencio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Terencio. The network helps show where J. Terencio may publish in the future.

Co-authorship network of co-authors of J. Terencio

This figure shows the co-authorship network connecting the top 25 collaborators of J. Terencio. A scholar is included among the top collaborators of J. Terencio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Terencio. J. Terencio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Allué, José Antonio, Leticia Sarasa, Noelia Fandos, et al.. (2025). Clinical validation of a plasma-based antibody-free LC–MS method for identifying CSF amyloid positivity in mild cognitive impairment. Frontiers in Aging Neuroscience. 17. 1681516–1681516.

Allué, José Antonio, María Pascual‐Lucas, Leticia Sarasa, et al.. (2023). Clinical utility of an antibody‐free LC‐MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 15(2). e12451–e12451. 5 indexed citations

Pascual‐Lucas, María, Leticia Sarasa, Sergio Castillo, et al.. (2023). AB1601 Phase 2 Study of ABvac40, an Anti‐Aβ40 Vaccine: Safety and Immunogenicity of a Cross‐Over Extension. Alzheimer s & Dementia. 19(S24). 2 indexed citations

Calderón‐Gómez, Elisabeth, et al.. (2022). Systems biology and artificial intelligence analysis highlights the pleiotropic effect of IVIg therapy in autoimmune diseases with a predominant role on B cells and complement system. Frontiers in Immunology. 13. 901872–901872. 8 indexed citations

Sierra, Josep M., et al.. (2009). Decreased linezolid uptake in an in vitro-selected linezolid-resistant Staphylococcus epidermidis mutant. Journal of Antimicrobial Chemotherapy. 64(5). 990–992. 12 indexed citations

Zamora, Ismael, Maria Piqué, Jordi Teixidó, et al.. (2007). Scaffold hopping: Application to the discoverty of novel GABAa receptor ligands. Afinidad. 64(529). 324–328. 1 indexed citations

Terencio, J., et al.. (2007). Retroperitoneal white adipose tissue lipoprotein lipase activity is rapidly down-regulated in response to acute stress. Journal of Lipid Research. 48(4). 863–868. 11 indexed citations

Piqué, Maria, Miguel A. González, Eva Méndez, et al.. (2006). Synthesis, pharmacology and molecular modeling of N-substituted 2-phenyl-indoles and benzimidazoles as potent GABAA agonists. European Journal of Medicinal Chemistry. 41(8). 985–990. 63 indexed citations

Marco‐Contelles, José, Rafael León, Cristóbal de los Rı́os, et al.. (2006). Novel Multipotent Tacrine−Dihydropyridine Hybrids with Improved Acetylcholinesterase Inhibitory and Neuroprotective Activities as Potential Drugs for the Treatment of Alzheimer's Disease. Journal of Medicinal Chemistry. 49(26). 7607–7610. 107 indexed citations

10.

Méndez, Eva, et al.. (2005). A spectrophotometric assay for the determination of 4-diphosphocytidyl-2-C-methyl-d-erythritol kinase activity. Analytical Biochemistry. 340(2). 245–251. 16 indexed citations

11.

Teixidó, Jordi, José I. Borrell, Eva Méndez, et al.. (2005). Design, synthesis and biological activity of acyl substituted 3-amino-5-methyl-1,4,5,7-tetrahydropyrazolo[3,4-b]pyridin-6-ones as potential hypnotic drugs. European Journal of Medicinal Chemistry. 40(11). 1179–1187. 26 indexed citations

12.

Guillén, Jaime, et al.. (2003). Plasma proteins in leprosy.. PubMed. 22(1). 47–54.

13.

Barnass, Stella, J K Steele, Pedro Henrique Monteiro Torres, et al.. (1986). Prevalence and specificity of the enhancing effect of three types of interleukin 2 on T cell responsiveness in 97 lepromatous leprosy patients of mixed ethnic origin.. PubMed. 64(1). 41–9. 10 indexed citations

14.

Castells, Antoni, et al.. (1985). Thymopentin treatment in patients with chemotherapy-resistant lepromatous leprosy. PubMed. 4(S1). 63–69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact